NES and carcinoma of esophagus: Nestin was further investigated as it was found to correlate with decreased overall survival in patients with oesophageal cancer  when using  the in silico microarray meta-analysis tool PrognoScan (Fig. 5a), suggesting  its  important role in OAC biology.